MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Quality of life assessment in patients with Parkinson’s disease

    S. Frikha, O. Ben Othmen, M. Ben Mahmoud, S. Fray, H. Jamoussi, M. Fredj, N. Ben Ali (Tunis, Tunisia)

  • Quality of Life in Parkinson’s Disease Patients with Sleep Disturbances

    C. Falup-Pecurariu, L. Ungureanu, R. Filip, I. Murasan, B. Opritoiu, A. Zarnoveanu, S. Diaconu (Brasov, Romania)

  • Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): PDQ-39 Results from a Phase 3 Randomized Active-Controlled Study

    H. Sarva, M. Tagliati, W. Poewe, F. Stocchi, O. Rascol, T. Yardeni, N. Lopes, J. Pereira, A. Espay (New York, USA)

  • Quantification of an Upper Limb Rigidity Network in Parkinson Disease

    M. Bange, H. Ding, N. Koirala, M. Reich, C. Ip, B. Nasseroleslami, G. Deuschl, J. Volkmann, M. Muthuraman (Augsburg, Germany)

  • Quantification of Neuroinflammation and White Matter Injury in Parkinson Disease Using Diffusion Basis Spectrum Imaging

    R. White Iii, J. Rutlin, B. Maiti, M. Campbell, J. Shimony, J. Perlmutter (Saint Louis, USA)

  • Quantitative Analysis of the Biomechanical Contributors during the miniBEST Clinical Scale for Assessing Risk of Falling in Parkinson’s Disease

    T. Fitzgerald, C. O'Keeffe, J. Inocentes, E. Murphy, M. Bradley, C. Fearon, R. Reilly (Dublin, Ireland)

  • Quantitative Assessment of X-linked Dystonia-Parkinsonism Using Wearable Sensing Technology

    G. Corniani, G. Del Duca, S. Sanseverino, N. Ganza, S. Begalan, C. Nelson, P. Acuna, C. Go, N. Sharma, P. Bonato, C. Stephen (Boston, USA)

  • Quantitative EEG Analysis for Comparing Drug-Induced Parkinsonism and Parkinson’s Disease

    S. Seo, S. Kim, SP. Kim, J. Kim, D. Chung, SY. Kang (Ulsan, Republic of Korea)

  • RAB32 c.213C>G (p.Ser71Arg) explains Parkinson’s disease in two UK families: description of the clinical and biochemical features

    R. Tilney, R. Real, E. Gustavsson, S. Jasaityte, Y. Kordovska, M. Fenn, P. Korlipara, M. Hu, E. Sammler, M. Farrer, H. Morris (London, United Kingdom)

  • RAB32 variant p.Ser71Arg in the ROstock PArkinson’s Disease Study (ROPAD)

    C. Beetz, M. Radefeldt, K. Tripolszki, P. Bauer (Rostock, Germany)

  • « Previous Page
  • 1
  • …
  • 135
  • 136
  • 137
  • 138
  • 139
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Comorbid Normal Pressure Hydrocephalus with Parkinson’s disease: a call for clinical awareness
  • Common mistakes in the MoCA test in patients with Parkinson’s Disease in Kyrgyzstan
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley